2019 News Briefs - International Neuromodulation Society

Earlier News:

2019

Neurostimulation Company Releases Six-Month Study Data

Jan. 17, 2019 - Stimwave released six-month data from a trial of its spinal cord stimulation system in patients with back and leg pain, in which high or low frequency stimulation was used. (Mass Device)

First Patient Enrolled in Study of Intrathecal Drug Delivery in Pain Patients Who Were Weaned Off of Oral Opioids

Jan. 17, 2019 - Medtronic announced enrollment of the first patient in a study of the use of its intrathecal drug delivery device in people with chronic intractable non-malignant primary back pain who have been weaned off of oral opioids. (Drug Delivery Business News)

Annual Research Prize for Junior Investigators Announced

Jan. 16, 2019 - There is a March 15, 2019 deadline for junior investigators aged 45 or younger, who have received an advanced degree in the past 10 years, to submit an entry for the Science and PINS Prize in Neuromodulation. The $25,000 prize is based on an essay about research performed in the past three years. The award was started in 2016 by Science magazine and PINS Medical of China. In addition to the cash award, winners have their essay published in Science magazine. (Science 2.0)

Israeli Company Prepares for US. Stock Exchange Offering

Jan. 15, 2019 - Brainsway Ltd. has filed a prospectus for a public offering on Nasdaq to raise at least $30 million. Timing of the offering depends upon when approval of the prospectus is received from the U.S. Securities and Exchange Commission, which was affected by the U.S. government shutdown. (Globes)

Industry Observers Discuss the Role of Neuromodulation in Pain Treatment

Jan. 15, 2019 - A news feature about neuromodulation and pain presents viewpoints about a larger context for the treatment, with one physician saying neuromodulation can be part of the answer to part of the opioid problem, and that with individual patients, expectation management is important. (Mass Device)

Company Plans Patient Registry

Jan. 14, 2019 - Bioness, Inc. announced that for its peripheral nerve stimulator, it has launched a patient registry, to which patients will be able to opt-in to join. (Cision)

Industry Association Unveils an Updated Code of Ethics

Jan. 9, 2019 - AdvaMed, the Advanced Medical Technology Association, has published an updated Code of Ethics on Interactions with U.S. Health Care Professionals that will take effect January 1, 2020. It updates guidance about a number of aspects, such as consulting arrangements, and adds guidance about factors such as conduct of company representatives and information about on- and off-label use of medical devices. (Lexology)

Column Presents Top Takeaways from an Expert Consensus Published in 2018

Jan. 11, 2019 - A column summarizes the top 10 takeaways from the 2018 publication, "The Neuromodulation Appropriateness Consensus Committee on Best Practices for Dorsal Root Ganglion Stimulation." (NeuroNews International)

Review Summarizes Reports on Advanced Methods of Spinal Cord Stimulation

Jan. 9, 2019 - Updating a review from 2014, a newly published review summarizes reports from 2010 - 2018 on "Advanced methods of spinal stimulation in the treatment of chronic pain: pulse trains, waveforms, frequencies, targets and feedback loops." (Expert Review of Medical Devices)

Headache Symposium Includes Preliminary Results from a Clinical Trial of a Wearable Device to Treat Migraine

Jan. 9, 2019 - Remarks at the 4th Annual International Headache Symposium in Israel included preliminary results of a randomized, double-blind, parallel group, sham-controlled clinical trial of a migraine treatment device that stimulates the occipital and trigeminal nerves. (Business Wire)

Thought Leader Calls for Ottawa to Fund Better Mental Health Treatments

Jan. 9, 2019 - A medical columnist points out that more than 16 years after Health Canada approved repetitive transcranial magnetic stimulation for depression, the only provincial health authorities to cover the treatment are in Quebec and Saskatchewan. (Ottawa Citizen)

A Personal Account of Choosing Neurostimulation to Treat Peripheral Neuropathy Pain

Jan. 9, 2019 - A news feature tells the story of a man who developed peripheral neuropathy and chose neurostimulation rather than surgery to treat the chronic pain. (University of Kentucky)

Current Neuromodulation Treatments for Migraine Considered

Jan. 8, 2019 - An article summarizes the state of neuromodulation devices approved for migraine treatment. (Medscape)

Company Reports New Clinical Trials in Noninvasive Vagus Nerve Stimulation for Migraine

Jan. 8, 2019 - ElectroCore, Inc. announced two clinical studies focused on expanding the use of non-invasive vagus nerve stimulation for acute and preventive treatment of migraine. The company also noted publication of a retrospective analysis of the treatment in a clinical trial in cluster headache patients. (Globe Newswire)

Visual Prosthetic Meets Six-Month Endpoints in Feasibility Study

Jan. 8, 2019 - Pixium Vision reported interim six-month follow-up results of a feasibility study of its visual prosthetic implant, a wireless sub-retinal photovoltaic microchip, in patients with advanced dry age-related macular degeneration. (Pharmalive)

Researchers Study Effect of Transcranial Stimulation on Motor Behavior

Jan. 4, 2019 - Researchers at the University of Tokyo studied the effect of transcranial static magnetic field stimulation (tSMS) on motor behavior in healthy subjects. The stimulation modulates cortical excitability. The researchers compared ballistic pinch force control before, during and after tSMS and sham interventions. (Neuromodulation: Technology at the Neural Interface)

Multicenter Study Reports Five-Year Experience of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction

Jan. 4, 2019 - A group of co-authors report on a five‐year, retrospective, multicenter study in China that evaluated the long‐term safety and efficiency of sacral neuromodulation in patients with urinary voiding dysfunction. (Neuromodulation: Technology at the Neural Interface)

FDA Clears Sinus Pain Device

Jan. 3, 2019 - TIVIC Health systems Inc. announced 510(k) clearance from the FDA for its transcutaneous, hand-held neurostimulation device to treat sinus pain due to allergic rhinitis. (PR Newswire)

New Device Company Launches

Jan. 3, 2019 - Dr. V. Reggie Edgerton announced formation of SpineX, a Los Angeles-based medical device company developing non-invasive devices to stimulate the spinal cord. (Globe Newswire)

Journal Article Categorizes Intervention Complications

Jan. 3, 2019 - Co-authors categorized complications for dorsal root ganglion stimulation for pain relief, which were reported in the MAUDE (Manufacturer and User Facility Device Experience) database. (Regional Anesthesia & Pain Medicine)

Neurostimulation Company Divests Subsidiary Focused on Neuroscience Clinical Animal Research Technology

Jan. 2, 2019 - Nuvectra Corporation announced it has agreed to sell its subsidiary NeuroNexus Technologies, Inc. to NEL Group, Inc., for $5 million in cash. (Globe Newswire)

Last Updated on Friday, January 18, 2019 01:34 PM